Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    Sorry, I don't understand. Please try again

    1. Home/
    2. Our company/
    3. Suppliers/
    4. Supplier-enabled innovation

    Supplier-enabled innovation

    Johnson & Johnson has built a strong, resilient supply base by integrating its suppliers as an expansion of our network and capabilities. Our suppliers reflect all facets of the communities we serve. Through our supplier-enabled innovation program, we leverage their diverse and unique expertise to co-create innovative solutions that address unmet needs and reimagine the future of health.
    The arm of a person wearing a smartwatch pointing to a laptop screen

    Suppliers

    Our suppliers help us fulfill our mission to help transform healthcare with innovative supplier solutions.

    Securing the future of surgery, one staple at a time

    Faced with the challenge of improving stapling performance for consistent outcomes in challenging tissue, Ethicon drew inspiration from its broad and talented supplier base.

    At the heart of innovation: How China’s procurement team and AI are helping AFib patients

    In China, when the need for a highly advanced, nonsurgical treatment for atrial fibrillation (AFib) exceeded the supply of doctors trained in the lifesaving procedure, Johnson & Johnson’s Procurement team asked for a chance to help. Thanks to quick actions and truly disruptive thinking, a new innovation in sourced artificial intelligence (AI) is now responsible for training physicians and, in turn, changing the trajectory of health for AFib patients throughout the country.

    Curing cancer from within: The promise of cell therapy

    Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.

    3 cutting-edge eye lenses designed to help improve how you see

    Multifocal contacts based on your pupil size. Intraocular lenses that adapt to our digital world. These are just some of the new Johnson & Johnson advances poised to change the future of vision care.

    More from Johnson & Johnson

    Striving for a cure for multiple myeloma: What HCPs need to know

    Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer.

    The future of immunology

    Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

    What is IL-23?

    This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat immune-mediated diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.